Alessandro Sanitin/LinkedIn
Apr 7, 2026, 13:50
Alessandro Santin Discusses New Targets in Rare Endometrial Disease – Yale Obstetrics, Gynecology and Reproductive Sciences
Yale Obstetrics, Gynecology and Reproductive Sciences shared a post on LinkedIn:
” ‘It’s only when you acquire the type of deep knowledge in the molecular characteristic that you may really identify potential targets,’ says our own Yale Ob/Gyn’s Alessandro Sanitin, MD.
In an interview with Contemporary OB/GYN, Dr. Santin discusses his investigation of new treatments for rare endometrial disease.
Read and/or listen here.”
Stay updated on all scientific advances in the field of fertility with Fertility News.
-
Aug 9, 2026, 15:46Aevum Bio Clinic Is Recruiting a Women’s Health and Fertility Doctor
-
Aug 9, 2026, 15:36How Do GLP1 Drugs Impact Egg Quality? – Noor Sciences
-
Aug 9, 2026, 15:19Aleesha Grier: Something Powerful Happens When We Bring Assisted Reproductive Healthcare Into the Light
-
Aug 9, 2026, 15:00Kiani Davis: Providing Information Isn’t Necessarily the Same As Providing Education
-
Aug 9, 2026, 13:525 Evidence-Based Reasons Not to “Just Keep Trying” – Fertility Plus
-
Aug 9, 2026, 13:34The Future of Embryology Depends on How We Train the Next Generation – ASRM
-
Aug 9, 2026, 13:22Ritik Shukla: Menopause Is Not the End of Vitality – It’s the Beginning of a New Chapter
-
Aug 9, 2026, 12:57Szabó Gábor: 2 Imaging Modalities for Detecting Endometriosis
-
Aug 9, 2026, 12:36Shehab Gamal: Your Fertility Might Be Sitting in Your Fridge